FindTrial
Sign In

Effect of ropivacaine combined with dexmedetomidine in thoracolumbar interfascial plane block on postoperative analgesia in multi-segmental lumbar fusion

Effect of ropivacaine combined with dexmedetomidine in thoracolumbar interfascial plane block on postoperative analgesia in multi-segmental lumbar fusion

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2100049058
Enrollment
Unknown
Registered
2021-07-20
Start date
2021-07-10
Completion date
Unknown
Last updated
2022-04-04

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

multi-segmental lumbar fusion

Interventions

ropivacaine group:ropivacaine
ropivacaine combined with dexmedetomidine group:ropivacaine combined with dexmedetomidine
Control Group:none

Sponsors

Tianjin People's Hospital
Lead Sponsor

Eligibility

Sex/Gender
All
Age
20 Years to 70 Years

Inclusion criteria

Inclusion criteria: It is clearly diagnosed with lumbar spinal stenosis or lumbar spondylolisthesis at 3 to 4 levels and the lumbar vertebraat is required to fusion.

Exclusion criteria

Exclusion criteria: Serious cardiopulmonary disease, severe hypertension,sequelae of cerebrovascular disease, bradycardia, abnormal behavior, long-term use of the following drugs (ß-receptor blocker, analgesic), liver and kidney function abnormal, allergic to ropivacaine and a2 adrenergic receptor agonist.

Design outcomes

Primary

MeasureTime frame
Resting/Movement Visual Analogue Score;Bruggrmann Comfort Scale;the duration of analgesia;total length of hospitalization stay;intraoperative remifentanil and propofol dosage;the pressing times of PCIA pump;consumption of fentanil;—

Secondary

MeasureTime frame
rate of adverse reactions;—

Countries

China

Contacts

Public ContactYang Xuewei

Tianjin People's Hospital

shankun1976@126.com+86 18920903796

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026